Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 96

    Unichem Laboratories gets USFDA nod to market BP drug Chlorthalidone tablet

    Unichem Laboratories gets USFDA nod to market BP drug Chlorthalidone tablet

    Medical Dialogues Bureau12 Aug 2019 1:37 PM IST
    Drug firm Unichem Laboratories has received approval from the US health regulator to market Chlorthalidone tablets, used to treat high blood...
    CK Birla Hospital for Women to invest up to Rs 1,000 cr, add 14 hospitals by end of 2025

    CK Birla Hospital for Women to invest up to Rs 1,000 cr, add 14 hospitals by end of 2025

    Medical Dialogues Bureau12 Aug 2019 1:36 PM IST
    NEW DELHI: Healthcare provider CK Birla Hospital for Women is planning to invest up to Rs 1,000 crore to add around 14 more hospitals under the brand...
    Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni

    Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni

    Medical Dialogues Bureau12 Aug 2019 12:26 PM IST
    New Delhi: Natco Pharma is focusing on filing of cancer treatment drugs in China, the world's second largest pharmaceutical market, as part of its...
    Ex-Eagle Scout accused in online drug empire to stand trial

    Ex-Eagle Scout accused in online drug empire to stand trial

    Medical Dialogues Bureau12 Aug 2019 9:28 AM IST
    SALT LAKE CITY: A 29-year-old former Eagle Scout accused of running a multimillion-dollar opioid drug ring out of his suburban Salt Lake City basement...
    Not withholding interim compensation from patients who want more: JnJ to HC

    Not withholding interim compensation from patients who want more: JnJ to HC

    Medical Dialogues Bureau11 Aug 2019 3:30 PM IST
    The government's contention was opposed by JnJ which said it had paid more people than just 67 and told the court that it will provide a list of the...
    USFDA completes audit of Louisiana-based facility with no observations: Dr Reddys

    USFDA completes audit of Louisiana-based facility with no observations: Dr Reddys

    Farhat Nasim11 Aug 2019 9:48 AM IST
    As per the USFDA, Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that...
    Sterling Biotech Money Laundering Case: Relief to co-accused as Delhi HC junks ED plea to cancel bail

    Sterling Biotech Money Laundering Case: Relief to co-accused as Delhi HC junks ED plea to cancel bail

    Medical Dialogues Bureau11 Aug 2019 9:47 AM IST
    Justice Sunil Gaur said the accused deserve bail on merits and the orders granting them relief is not liable to be interfered with as the impugned...
    Strides Pharma gets zero USFDA observations for Alathur facility

    Strides Pharma gets zero USFDA observations for Alathur facility

    Medical Dialogues Bureau11 Aug 2019 9:31 AM IST
    The company's formulation facility at Alathur in Chennai underwent a United States Food and Drug Administration (USFDA) inspection from August 5 to 9,...
    Bayer mediator dismisses report of USD 8 billion Roundup settlement

    Bayer mediator dismisses report of USD 8 billion Roundup settlement

    Medical Dialogues Bureau11 Aug 2019 9:15 AM IST
    Roundup is the flagship weed-killing product of Monsanto, the American seeds and pesticides maker that Bayer bought last year in a mammoth $63 billion...
    Canada enacts drug price crackdown, in blow to pharmaceutical industry

    Canada enacts drug price crackdown, in blow to pharmaceutical industry

    Medical Dialogues Bureau11 Aug 2019 9:00 AM IST
    The changes are the biggest reform to Canada's drug price regime since 1987 and could eventually cut the earnings of drugmakers in the United States,...
    Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1

    Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1

    Medical Dialogues Bureau10 Aug 2019 12:43 PM IST
    During the quarter, Zydus Cadila entered into a marketing alliance with SIFI, the Italian leader in the development of therapeutic solutions for...
    USFDA completes inspection of Nagpur facility with no observations: Lupin

    USFDA completes inspection of Nagpur facility with no observations: Lupin

    Medical Dialogues Bureau10 Aug 2019 9:30 AM IST
    The inspection by the US Food and Drug Administration (USFDA) for a facility at Nagpur was carried out between August 5, 2019, and August 8, 2019. It...
    PrevNext

    Popular Stories

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok